Nelson G I, Verma S P, Hussain M, Silke B, Forsyth D, Abdulali S, Taylor S H
J Cardiovasc Pharmacol. 1984 Mar-Apr;6(2):331-8. doi: 10.1097/00005344-198403000-00019.
A randomised between-group study of the immediate haemodynamic effects of venodilatation by intravenous isosorbide dinitrate infusion (50-200 micrograms/kg/h) and arteriolar dilatation by intravenous hydralazine bolus (0.15 mg/kg) given either in random sequence (Groups 1 and 2; n = 12) or simultaneously (Group 3; n = 6) was undertaken in 18 men with radiographic and haemodynamic evidence (left ventricular [LV] filling pressure greater than 20 mm Hg) of LV failure 6-19 h following acute myocardial infarction. Control measurements (1 h) preceded either two consecutive 90-min treatment periods (Groups 1 and 2) or a single 90-min period (Group 3). Given independently, both drugs reduced systemic arterial pressure and vascular resistance, whereas only isosorbide dinitrate reduced LV filling pressure and only hydralazine increased cardiac output and stroke volume. Isosorbide dinitrate/hydralazine in combination significantly reduced LV filling pressure, systolic and diastolic arterial pressure, and total systemic vascular resistance. Cardiac output, stroke volume, and heart rate were increased. In conclusion, combined arteriolar dilatation and venodilatation appears to be of greater haemodynamic benefit than either alone, if the fall in mean systemic pressure does not compromise peripheral perfusion.
对18名急性心肌梗死后6 - 19小时出现左心室(LV)衰竭影像学和血流动力学证据(左心室充盈压大于20 mmHg)的男性患者进行了一项随机组间研究,以比较静脉输注硝酸异山梨酯(50 - 200微克/千克/小时)引起的静脉扩张和静脉注射肼屈嗪推注(0.15毫克/千克)引起的小动脉扩张的即时血流动力学效应。随机序列给予(第1组和第2组;n = 12)或同时给予(第3组;n = 6)。在两个连续的90分钟治疗期(第1组和第2组)或一个90分钟治疗期(第3组)之前进行对照测量(1小时)。单独使用时,两种药物均降低了体循环动脉压和血管阻力,而只有硝酸异山梨酯降低了左心室充盈压,只有肼屈嗪增加了心输出量和每搏量。硝酸异山梨酯/肼屈嗪联合使用显著降低了左心室充盈压、收缩压和舒张压以及总体循环血管阻力。心输出量、每搏量和心率增加。总之,如果平均体循环压力下降不影响外周灌注,联合小动脉扩张和静脉扩张似乎比单独使用任何一种药物具有更大的血流动力学益处。